Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cures Bill Authorizes 'Intercenter Institutes,' But Will US FDA Create Them?

Nov 28 2016

• By Derrick Gingery

Capitol House

Related Content

Rare Disease Integration Into FDA Reviews Will Grow Under PDUFA VI

Jul 18 2016

ORA Device Director: Inspection 'Program Alignment' Scheme Not Ready Anytime Soon; Investigator Training, Retention Pose Challenge For FDA

May 17 2016

FDA 'Intercenter Institutes' Legislation Headed For Senate Mark-Up

Mar 28 2016

Look Before Leaping To Reorganize FDA – Former Commissioner McClellan

Mar 14 2016

Finally … Rachel Sherman Takes Califf's Old FDA Job

Sep 22 2016

21<sup>st</sup> Century Cures Revisions Tell FDA To Highlight ‘Patient Experience Data’

Nov 28 2016

FDA's Pazdur To Retain Drug Approval Duties In Oncology Center Of Excellence

Nov 07 2016

PDUFA VI: NORD Wants Reviewers To Be More Accessible

Aug 18 2016

FDA's Pazdur Jumps Over To New 'Moonshot' Role

Jun 30 2016

Additional Topics

United States Drug Review Legislation Regulation FDA BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window